A single‑dose oral challenge appears safe for identifying adults with unnecessary, low‑risk sulfa antibiotic allergy labels, researchers report.
After decades of losing ground to drug resistance, doctors finally have new weapons against gonorrhoea, a common sexually transmitted infec.